IM Medical may be trading at just under 1¢, but the company is quite sure and telling the market about its future growth.
IMI's main product, theIntelliheart system, measures the hardening of the arteries and tests for and analyses cardiovascular disease.
There are 30 clinics in Melbourne with their machines, and with plans to double that number by Christmas. There is a buzz at the head office as they are already counting next year's profit.
The machines cost $25,000 each, and each machine generates $165 per patient per year, this is for an initial test and two follow-ups.
At the current cash burn rate the company only has enough money left in the bank for 1 year. Nevertheless, the company now beleives it will be banking profits of $1 million a quarter by the start of the 4th quarter.
IMI is now forecasting that it will recors $4m in profit and be capitalised at $40-50 million dollars by the end of the 4th quarter.
If this occurs that would be a more than fivefold increase in the market cap in a time frame of about 12 months.
The company, which is capped at the moment at approximately $7m, also has plans to acquire AusEmed shortly.
Current share price is $.009, if they hit their 2006-07 FY earning they will probably be trading at $.08 +
Huge multi bagger potential here.
Get ready for he Launch in my opinion.
DYOR,
Nasi
IMI Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
